Literature DB >> 22917547

Effects of renal sympathetic denervation on heart rate and atrioventricular conduction in patients with resistant hypertension.

Christian Ukena1, Felix Mahfoud, Aline Spies, Ingrid Kindermann, Dominik Linz, Bodo Cremers, Ulrich Laufs, Hans-Ruprecht Neuberger, Michael Böhm.   

Abstract

BACKGROUND: Renal sympathetic denervation (RDN) reduces sympathetic activity and blood pressure (BP) in patients with resistant hypertension. The present study aimed to investigate the effects of RDN on HR and other electrocardiographic parameters.
METHODS: 136 patients aged 62.2 ± 0.8 years (58% male, BP 177 ± 2/93 ± 1 mmHg) with resistant hypertension underwent RDN. BP and a 12-lead electrocardiogram (ECG) were recorded before, 3 months (n=127), and 6 months (n=88) after RDN.
RESULTS: After 3 months (3M) and 6 months (6M), systolic BP was reduced by 25.5 ± 2.4 mmHg (p<0.0001) and 28.1 ± 3 mmHg (p<0.0001). HR at baseline was 66.1 ± 1 beats per minute (bpm) and was reduced by 2.6 ± 0.8 bpm after 3 months (p=0.001) and 2.1 ± 1.1 bpm after 6 months (p=0.046). Patients with HR at baseline between 60-71 bpm and ≥ 71 bpm had a reduction of 2.9 ± 7.6 bpm (p=0.008) and 9.0 ± 8.6 bpm (p<0.0001), respectively, whereas in patients with baseline HR<60 bpm HR slightly increased after 3 months (2.7 ± 8.4 bpm; p=0.035). Neither baseline HR nor change of HR correlated with the reduction of systolic BP. The PR interval was prolonged by 11.3 ± 2.5 ms (p<0.0001) and 10.3 ± 2.5 ms (p<0.0001) at 3 and 6 months after RDN, respectively.
CONCLUSIONS: Renal sympathetic denervation reduced heart rate and the PR interval as indicators of cardiac autonomic activity.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cardiac autonomic activity; Renal nerve ablation; Resistant hypertension; SIMPLYCITY-HTN

Mesh:

Year:  2012        PMID: 22917547     DOI: 10.1016/j.ijcard.2012.07.027

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  37 in total

1.  Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension.

Authors:  Luca Donazzan; Felix Mahfoud; Sebastian Ewen; Christian Ukena; Bodo Cremers; Carl-Martin Kirsch; Dirk Hellwig; Tareq Eweiwi; Samer Ezziddin; Murray Esler; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2015-10-22       Impact factor: 5.460

Review 2.  Renal denervation: effects on atrial electrophysiology and arrhythmias.

Authors:  Dominik Linz; Arne van Hunnik; Christian Ukena; Sebastian Ewen; Felix Mahfoud; Stephan H Schirmer; Matthias Lenski; Hans-Ruprecht Neuberger; Ulrich Schotten; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2014-03-29       Impact factor: 5.460

Review 3.  Renal sympathetic denervation: applications in hypertension and beyond.

Authors:  Michael Böhm; Dominik Linz; Daniel Urban; Felix Mahfoud; Christian Ukena
Journal:  Nat Rev Cardiol       Date:  2013-06-18       Impact factor: 32.419

Review 4.  Review of the state of renal nerve ablation for patients with severe and resistant hypertension.

Authors:  Vinay Gulati; William B White
Journal:  J Am Soc Hypertens       Date:  2013-08-15

5.  Heart rate and heart rate variability in resistant versus controlled hypertension and in true versus white-coat resistance.

Authors:  A de la Sierra; D A Calhoun; E Vinyoles; J R Banegas; J J de la Cruz; M Gorostidi; J Segura; L M Ruilope
Journal:  J Hum Hypertens       Date:  2014-01-09       Impact factor: 3.012

Review 6.  Novel and nonpharmacologic approaches to cardio-protection in hypertension.

Authors:  Luca Donazzan; Felix Mahfoud; Dominik Linz; Sebastian Ewen; Christian Ukena; Michael Böhm
Journal:  Curr Hypertens Rep       Date:  2014-05       Impact factor: 5.369

Review 7.  Renal denervation therapy for resistant hypertension: a clinical update.

Authors:  C V S Ram; A S Kumar
Journal:  J Hum Hypertens       Date:  2014-03-06       Impact factor: 3.012

Review 8.  Modulation of renal sympathetic innervation: recent insights beyond blood pressure control.

Authors:  Dominik Linz; Mathias Hohl; Adrian D Elliott; Dennis H Lau; Felix Mahfoud; Murray D Esler; Prashanthan Sanders; Michael Böhm
Journal:  Clin Auton Res       Date:  2018-02-10       Impact factor: 4.435

Review 9.  Interventional treatment of hypertension: a new paradigm.

Authors:  W Schuyler Jones; Sreekanth Vemulapalli; Manesh R Patel
Journal:  Curr Cardiol Rep       Date:  2013-05       Impact factor: 2.931

10.  Renal denervation for treatment of ventricular arrhythmias: data from an International Multicenter Registry.

Authors:  Christian Ukena; Felix Mahfoud; Sebastian Ewen; Andreas Bollmann; Gerhard Hindricks; Boris A Hoffmann; Dominik Linz; Dan Musat; Valerie Pavlicek; Eberhard Scholz; Dierk Thomas; Stephan Willems; Michael Böhm; Jonathan S Steinberg
Journal:  Clin Res Cardiol       Date:  2016-06-30       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.